Skip to main content
OpenTrials

Clinical trial condition

von Hippel-Lindau Disease

Explore clinical trials studying von Hippel-Lindau Disease. Study availability and eligibility vary by location and protocol.

42 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

von Hippel-Lindau Disease trial results

Active, Not Recruiting

A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)

NCT03401788

Conditions
Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +14 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions